Biotechnology News

November 27, 2012

DENVER & ATLANTA--(BUSINESS WIRE)--The Global Down Syndrome Foundation and the National Down Syndrome Congress have announced distribution agreements for the hallmark Down Syndrome Prenatal Testing Pamphlet that provides current, accurate...

November 27, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bracco Diagnostics Inc. (BDI) is voluntarily initiating a Class I recall of nine (9) lots of Isovue® (iopamidol injection) Pre-Filled Power Injector Syringes (Isovue PFS, to be used in combination with Stellant®...

November 27, 2012

SEATTLE--(BUSINESS WIRE)--November 27, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced that management will present at the following conferences: 2012 dbAccess BioFEST in Boston, MA, on December 4, 2012, at 2:15 p.m. ET 31st Annual J.P....

November 27, 2012

PHILADELPHIA--(BUSINESS WIRE)--Chemtura Corporation (NYSE/EuroNext Paris: CHMT) today announced that Stephen Forsyth, Executive Vice President and Chief Financial Officer, will present at the Bank of America Merrill Lynch 2012 Leverage Finance...

November 27, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics announced today that the waterproof Neptune sound processor has passed rigorous internal testing and is now warranted for use in oceans, lakes and rivers.

November 27, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced that it has enrolled the first patient in a Phase 2 clinical trial of ELND005 (Study AG201) for the treatment of agitation/aggression in patients with moderate to severe...

November 27, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread® (tenofovir disoproxil fumarate). The first...

November 27, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the 2012 Deutsche Bank BioFEST Conference in Boston on Tuesday, December 4, 2012 at 10:10 a.m. ET. The presentation will be available as a live webcast...

November 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Deutsche Bank 2012 dbAccess BioFEST on Monday, December 3...

November 27, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company's quarterly dividend to $0.43 per outstanding share of the company's common...

November 27, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--RedHill Biopharma Ltd. (TASE:RDHL), an Israeli biopharmaceutical company focusing primarily on acquisition and development of late clinical-stage, patent-protected, new formulations and combinations of existing...

November 27, 2012

WASHINGTON--(BUSINESS WIRE)--Now in its fifteenth year, the BIO CEO & Investor Conference, hosted by BIO, is the largest independent investor conference focused on publicly-traded biotechnology companies.

November 27, 2012

LONDON--(BUSINESS WIRE)--Edison has today published a comprehensive report titled Bruised but not done, examining the investment merits of ArQule, focusing on the potential of its lead program, tivantinib.

November 27, 2012

NORTHRIDGE, Calif.--(BUSINESS WIRE)--Gamma Medica, Inc. is developing biopsy capability for its LumaGEM® Molecular Breast Imaging (MBI) System. Easy to use, software calculates depth, allows multiple biopsy, immediate confirmation.

November 27, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day in New York City on Tuesday, December 4, 2012 from 10:15 a.m. to 12:00 p.m. Eastern Time (7:15 a.m. to 9:00 a.m. Pacific Time) at the...

November 27, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--ACM Global Central Laboratory has expanded its clinical trials testing services in Europe with a larger, state-of-the art central lab facility

November 27, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the launch of LifeMap Discovery™ (discovery.lifemapsc.com), a state-of-the-art roadmap of embryonic development and stem cell...

November 27, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that while very few changes in practice patterns have been made thus far in anticipation...

November 27, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--In the United States, 59% of companies surveyed by Cutting Edge Information said that they assign a dedicated budget to health economics and outcomes research (HEOR).

November 27, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that members of its executive management are scheduled to present at the 2012...

November 27, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--Shareholder Letter discusses Name Change, Corp Restructure & Significant milestone in Phase 1 physician-initiated clinical trial for ovarian cancer

November 27, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences (Nasdaq:GILD) today announced topline results from the Phase 3 POSITRON study examining a 12-week course of once-daily sofosbuvir plus ribavirin (RBV) in patients with genotype 2 or 3 chronic...

November 27, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--CSA Medical announced the successful first patient procedures with the truFreeze® Spray Cryotherapy System.

November 27, 2012

FLEMINGTON, N.J.--(BUSINESS WIRE)--Arno Therapeutics, Inc. (ARNI.OB) today announced the closing of a private placement of $12.7 million of convertible debentures (the “Debentures”), which are convertible into shares of common stock at an initial...

November 27, 2012

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and sells prescription medical foods to physicians and pharmacies for the treatment of chronic disease,...

November 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--VSTM CEO adopts 10b5-1 plan to purchase company shares

November 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Z160, Zalicus' first-in-class, oral, N-type calcium channel (Cav 2.2) blocker for chronic neuropathic pain, has been chosen by Windhover as a Top 10 Project to Watch

November 27, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (OTCBB:ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-...

November 27, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the Deutsche Bank 2012 dbAccess BioFEST on Monday, December 3 at 10:45 a.m. (EST) in Boston. A live audio webcast and...

November 27, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl (NASDAQ: CELG) today announced that clinical investigators from leading cancer research centers will present data from recent and on-going clinical trials in more than 250 posters...

November 27, 2012

BOSTON--(BUSINESS WIRE)--China, the largest country & aging population has 2 very different markets–a Western-style in cities and a 3rd World in its villages, presenting many healthcare opportunities, says Lux Research.

November 27, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced successful top-line results from its pivotal Phase III trial evaluating the efficacy, tolerability and safety of pimavanserin in patients with Parkinson’s...

November 27, 2012

BOSTON--(BUSINESS WIRE)--BioSurplus announced today the opening of its new 20,000-square-foot showroom and warehouse located at 57 Water Street in Watertown, Massachusetts.

November 27, 2012

BOSTON--(BUSINESS WIRE)--BioSurplus will host an online auction of like-new research laboratory equipment and instruments from various consignors, to run December 6th through the 13th, 2012.

November 27, 2012

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: Artimplant (STO:ARTIB) has formed a Medical Advisory Board (MAB) in the US comprising leading surgeons with a diversity of expertise in the field of orthopedic and podiatric medicine. The...

November 27, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research publishes in Nucleic Acid Therapeutics demonstrating cholesterol-siRNA mediated knockdown in primates for the first time using DPC delivery system and novel co-injection strategy

November 27, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Expands Manufacturing Capacity to Ensure Long-Term Supply of FUSILEV®; FDA approves new manufacturing site, providing additional geographical diversification of supply.

November 27, 2012

LONDON--(BUSINESS WIRE)--New report “Nevirapine - Comprehensive patent search” elaborated by Genericsweb has been recently published at MarketPublishers.com

November 27, 2012

ZWINGENBERG, Germany--(BUSINESS WIRE)--BRAIN beschließt Finanzierungsrunde von 60 Mio. Euro zur Ausweitung der Buy and Build Strategie

Eingeworbenes Kapital unterstützt BRAIN auf dem Weg zu voll integriertem Industrieunternehmen

November 27, 2012

GRAMBACH/GRAZ, Austria & CAIRO--(BUSINESS WIRE)--Therapeutic, Recombinant Human Serum Albumin (rHSA) - VTU Technology Signs Agreement with Minapharm Pharmaceuticals

November 27, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) announced with sadness that Abraham (Barry) E. Cohen, a member of its Board of Directors, passed away on Thursday, November 22, 2012 at the age of 76. Mr. Cohen has been a valued...

November 26, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--Viral Genetics, Inc. (OTC Pink: VRAL) today announced that it has changed its name to VG Life Sciences Inc. and that it has completed its 1-for-600 reverse stock split, both of which will take effect at the...

November 26, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

November 26, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at Deutsche Bank Access BioFEST 2012

November 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Industry vets Lawton and Kauffman join VSTM Board of Directors

November 26, 2012

BEND, Ore.--(BUSINESS WIRE)--A detailed analysis of every biomarker-based IVD test approved by FDA since 2008. Includes overall approval trends plus detailed trends in novel tests, company activity, targets, & FDA review period.

November 26, 2012

NORWALK, Conn. & WASHINGTON--(BUSINESS WIRE)--The MMRF and the U.S. Department of Veterans Affairs (VA) today announced an unprecedented public/private partnership to accelerate the development of Personalized Medicine for multiple myeloma....

November 26, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through 2021, small-molecule angiogenesis inhibitors will dominate the renal cell...

November 26, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Data at Upcoming Scientific Meetings